14.77
price down icon1.20%   -0.18
after-market Handel nachbörslich: 14.77
loading
Schlusskurs vom Vortag:
$14.95
Offen:
$14.85
24-Stunden-Volumen:
1.94M
Relative Volume:
1.98
Marktkapitalisierung:
$1.05B
Einnahmen:
$133.62M
Nettoeinkommen (Verlust:
$-177.37M
KGV:
-5.1107
EPS:
-2.89
Netto-Cashflow:
$23.50M
1W Leistung:
+13.35%
1M Leistung:
+59.68%
6M Leistung:
+52.27%
1J Leistung:
-30.85%
1-Tages-Spanne:
Value
$14.47
$15.07
1-Wochen-Bereich:
Value
$11.17
$15.37
52-Wochen-Spanne:
Value
$6.92
$27.24

Xencor Inc Stock (XNCR) Company Profile

Name
Firmenname
Xencor Inc
Name
Telefon
626-305-5900
Name
Adresse
465 N. HALSTEAD ST., PASADENA, CA
Name
Mitarbeiter
250
Name
Twitter
Name
Nächster Verdiensttermin
2025-08-01
Name
Neueste SEC-Einreichungen
Name
XNCR's Discussions on Twitter

Vergleichen Sie XNCR mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
XNCR
Xencor Inc
14.77 1.07B 133.62M -177.37M 23.50M -2.89
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
416.81 104.76B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
481.67 63.06B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
578.05 60.32B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
843.66 51.55B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
165.76 34.49B 398.11M -1.03B -868.57M -5.7032

Xencor Inc Stock (XNCR) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-09-17 Fortgesetzt Barclays Underweight
2025-09-03 Herabstufung BofA Securities Buy → Neutral
2025-04-21 Eingeleitet William Blair Outperform
2024-12-12 Eingeleitet Wells Fargo Overweight
2024-12-02 Hochstufung Piper Sandler Neutral → Overweight
2024-04-16 Bestätigt BTIG Research Buy
2024-02-28 Herabstufung Piper Sandler Overweight → Neutral
2023-05-19 Eingeleitet BofA Securities Buy
2022-12-06 Eingeleitet Cowen Outperform
2022-10-13 Hochstufung Raymond James Outperform → Strong Buy
2022-09-21 Eingeleitet JP Morgan Overweight
2022-07-06 Fortgesetzt Canaccord Genuity Buy
2022-02-11 Eingeleitet BMO Capital Markets Outperform
2022-01-21 Eingeleitet SMBC Nikko Outperform
2021-12-15 Eingeleitet H.C. Wainwright Buy
2021-10-15 Fortgesetzt BTIG Research Buy
2021-02-24 Hochstufung Raymond James Mkt Perform → Outperform
2020-03-04 Eingeleitet Barclays Underweight
2020-02-25 Hochstufung Guggenheim Neutral → Buy
2020-01-30 Eingeleitet RBC Capital Mkts Outperform
2019-11-20 Fortgesetzt Guggenheim Neutral
2019-08-07 Herabstufung Guggenheim Buy → Neutral
2019-08-07 Herabstufung Raymond James Outperform → Mkt Perform
2019-06-13 Eingeleitet Mizuho Buy
2019-04-12 Eingeleitet Guggenheim Buy
2019-03-27 Eingeleitet Berenberg Buy
2019-03-15 Eingeleitet Raymond James Outperform
2018-09-10 Fortgesetzt BTIG Research Buy
2018-03-28 Fortgesetzt Leerink Partners Outperform
2017-03-02 Eingeleitet Instinet Neutral
2017-03-02 Bestätigt Wedbush Outperform
2016-10-04 Eingeleitet Piper Jaffray Overweight
2015-12-22 Eingeleitet Canaccord Genuity Buy
2015-08-05 Bestätigt MLV & Co Buy
2015-02-12 Bestätigt Oppenheimer Outperform
2015-01-28 Bestätigt MLV & Co Buy
2014-07-11 Eingeleitet Oppenheimer Outperform
Alle ansehen

Xencor Inc Aktie (XNCR) Neueste Nachrichten

pulisher
12:53 PM

How sustainable is Xencor Inc. stock dividend payoutEarnings Growth Summary & Safe Capital Allocation Plans - Trung tâm Dự báo KTTV quốc gia

12:53 PM
pulisher
12:25 PM

Why analysts remain bullish on Xencor Inc. stockJuly 2025 Setups & Accurate Trade Setup Notifications - newser.com

12:25 PM
pulisher
12:25 PM

What to expect from Xencor Inc. in the next 30 days2025 Growth vs Value & Long-Term Growth Stock Strategies - newser.com

12:25 PM
pulisher
11:30 AM

Forecasting Xencor Inc. price range with options dataMarket Growth Summary & Free High Return Stock Watch Alerts - newser.com

11:30 AM
pulisher
09:29 AM

Xencor To Present At AACR-NCI-EORTC International ConferenceWill It Make Waves? - RTTNews

09:29 AM
pulisher
05:23 AM

Can Xencor Inc. stock continue upward trendWeekly Stock Recap & Expert Verified Stock Movement Alerts - newser.com

05:23 AM
pulisher
05:23 AM

How to manage a losing position in Xencor Inc.July 2025 Levels & Stepwise Entry and Exit Trade Signals - newser.com

05:23 AM
pulisher
12:10 PM

Xencor Stock Soars to Day High with 13.44% Intraday Surge - Markets Mojo

12:10 PM
pulisher
Oct 16, 2025

Xencor Stock Hits Day Low of $11.17 Amid Price Pressure - Markets Mojo

Oct 16, 2025
pulisher
Oct 15, 2025

Will Xencor Inc. stock maintain momentum in 2025Dollar Strength & Weekly Top Performers Watchlists - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

What MACD and RSI say about Xencor Inc.2025 Key Lessons & Low Risk High Win Rate Stock Picks - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Published on: 2025-10-15 11:08:37 - newser.com

Oct 15, 2025
pulisher
Oct 15, 2025

Xencor stock maintains Overweight rating at Cantor Fitzgerald ahead of key webcast - Investing.com Nigeria

Oct 15, 2025
pulisher
Oct 15, 2025

Can a trend reversal in Xencor Inc. lead to recoveryPortfolio Return Summary & Capital Protection Trade Alerts - newser.com

Oct 15, 2025
pulisher
Oct 14, 2025

Xencor Stock Soars 7.14% to Intraday High Amid Strong Performance - Markets Mojo

Oct 14, 2025
pulisher
Oct 14, 2025

Xencor to present initial XmAb819 clinical data for renal cancer at conference - Investing.com Nigeria

Oct 14, 2025
pulisher
Oct 14, 2025

Xencor plans early-stage data for cancer drug (XNCR:NASDAQ) - Seeking Alpha

Oct 14, 2025
pulisher
Oct 14, 2025

Xencor Announces Presentation of Initial Phase 1 Dose-Escalation Results of XmAb819 in Clear Cell Renal Cell Carcinoma at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics - Business Wire

Oct 14, 2025
pulisher
Oct 14, 2025

Is Xencor Inc. (XE9) stock nearing a technical breakoutQuarterly Performance Summary & Fast Entry and Exit Trade Plans - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Reversal indicators forming on Xencor Inc. stock2025 Market Trends & Real-Time Buy Zone Alerts - newser.com

Oct 14, 2025
pulisher
Oct 14, 2025

Xencor Inc. stock prediction for this weekCEO Change & Short-Term Trading Opportunity Alerts - newser.com

Oct 14, 2025
pulisher
Oct 13, 2025

Published on: 2025-10-13 00:04:16 - newser.com

Oct 13, 2025
pulisher
Oct 11, 2025

Equities Analysts Issue Forecasts for Xencor FY2025 Earnings - MarketBeat

Oct 11, 2025
pulisher
Oct 11, 2025

Xencor, Inc. (NASDAQ:XNCR) Given Average Rating of “Moderate Buy” by Analysts - Defense World

Oct 11, 2025
pulisher
Oct 10, 2025

How hedge fund analytics apply to Xencor Inc. stockLayoff News & Verified Momentum Stock Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

How Xencor Inc. stock performs in rising dollar environmentMarket Risk Analysis & Trade Opportunity Analysis Reports - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

What’s next for Xencor Inc. stock priceJuly 2025 Setups & Safe Swing Trade Setup Alerts - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Xencor (NASDAQ:XNCR) Raised to Strong-Buy at Cantor Fitzgerald - MarketBeat

Oct 10, 2025
pulisher
Oct 10, 2025

What does recent volatility data suggest for Xencor Inc.July 2025 Reactions & Safe Capital Growth Plans - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Will Xencor Inc. (XE9) stock outperform small cap peersEarnings Overview Summary & Consistent Return Strategy Ideas - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

How to recover losses in Xencor Inc. stockJuly 2025 Fed Impact & Fast Entry High Yield Stock Tips - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Is Xencor Inc. stock recession proofJuly 2025 Rallies & Verified Entry Point Detection - newser.com

Oct 09, 2025

Finanzdaten der Xencor Inc-Aktie (XNCR)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$37.01
price up icon 1.84%
$87.57
price up icon 0.30%
$33.17
price up icon 1.28%
$105.14
price up icon 0.06%
biotechnology ONC
$316.42
price down icon 0.50%
$165.76
price up icon 1.57%
Kapitalisierung:     |  Volumen (24h):